Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine

NCT05109559 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

690

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV-2 Infection

Interventions

BIOLOGICAL: Full dose of Ad26.COV2. 5x10^10vp
BIOLOGICAL: Half dose of Ad26.COV2. 2.5x10^10vp
BIOLOGICAL: Full dose of Ad26.COV2. 5x10^10vp

Sponsor

Mahidol University

Collaborators

[object Object]
[object Object]
[object Object]